We are live on ! Find out more
Janney Montgomery Scott

Janney Montgomery Scott Portfolio holdings

AUM $40.4B
1-Year Est. Return 21.2%
This Fund
S&P 500
This Quarter Est. Return
+2.61%
1 Year Est. Return
+21.2%
3 Year Est. Return
+63.29%
5 Year Est. Return
+71.3%
10 Year Est. Return
+241.78%
AUM
$8.01B
AUM Growth
+$497M
Cap. Flow
+$334M
Cap. Flow %
4.17%
Top 10 Hldgs %
12.78%
Holding
1,861
New
128
Increased
1,041
Reduced
504
Closed
128

Sector Composition

Rank Sector Weight
1 Financials 9%
2 Healthcare 8.86%
3 Technology 7.49%
4 Industrials 6.82%
5 Communication Services 5.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EHI
1676
Western Asset Global High Income Fund
EHI
$175M
$141K ﹤0.01%
13,969
FRBA icon
1677
First Bank
FRBA
$451M
$140K ﹤0.01%
+12,000
New +$147K
GERN icon
1678
Geron
GERN
$911M
$139K ﹤0.01%
50,100
-11,000
-18% -$29.2K
NNY icon
1679
Nuveen New York Municipal Value Fund
NNY
$158M
$137K ﹤0.01%
13,500
VALE icon
1680
Vale
VALE
$62.9B
$137K ﹤0.01%
15,634
ESXB
1681
DELISTED
Community Bankers Trust Corporation
ESXB
$127K ﹤0.01%
15,342
S
1682
DELISTED
Sprint Corporation
S
$125K ﹤0.01%
+15,281
New +$127K
NSLR
1683
Neostellar Capital Corp
NSLR
$262M
$123K ﹤0.01%
33,713
-4,170
-11% -$15.7K
AGRX
1684
DELISTED
Agile Therapeutics
AGRX
$122K ﹤0.01%
+16
New +$111K
GAB icon
1685
Gabelli Equity Trust
GAB
$1.74B
$121K ﹤0.01%
20,224
+4,028
+25% +$23.8K
SITC icon
1686
SITE Centers
SITC
$230M
$121K ﹤0.01%
+10,356
New +$135K
CERS icon
1687
Cerus
CERS
$587M
$119K ﹤0.01%
47,600
-1,050
-2% -$3.36K
PETX
1688
DELISTED
Aratana Therapeutics, Inc.
PETX
$119K ﹤0.01%
16,400
+1,200
+8% +$7.38K
CEMP
1689
DELISTED
Cempra, Inc.
CEMP
$119K ﹤0.01%
25,900
+6,800
+36% +$26.9K
OCSI
1690
DELISTED
Oaktree Strategic Income Corporation
OCSI
$109K ﹤0.01%
13,400
-7,367
-35% -$58.2K
EGLT
1691
DELISTED
Egalet Corporation
EGLT
$109K ﹤0.01%
45,963
+500
+1% +$1.6K
STEW
1692
SRH Total Return Fund
STEW
$1.75B
$108K ﹤0.01%
11,145
MNTX
1693
DELISTED
Manitex International, Inc.
MNTX
$105K ﹤0.01%
+15,000
New +$105K
SGMO
1694
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$103K ﹤0.01%
11,678
OCUL icon
1695
Ocular Therapeutix
OCUL
$1.86B
$102K ﹤0.01%
11,000
-900
-8% -$8.71K
GMZ
1696
DELISTED
Goldman Sachs MLP Income Opportunities Fund
GMZ
$100K ﹤0.01%
+1,486
New +$105K
ERF
1697
DELISTED
Enerplus Corporation
ERF
$99K ﹤0.01%
12,238
-598
-5% -$4.72K
BXE
1698
DELISTED
Bellatrix Exploration Ltd.
BXE
$97K ﹤0.01%
33,440
-2,500
-7% -$8.71K
DLHC icon
1699
DLH Holdings
DLHC
$73.8M
$95K ﹤0.01%
17,650
+750
+4% +$3.88K
CHS
1700
DELISTED
Chicos FAS, Inc.
CHS
$95K ﹤0.01%
10,048
-31,460
-76% -$363K

Similar funds

Janney Montgomery Scott's Q2 2017 Portfolio in Review

As of Q2 2017, Janney Montgomery Scott held 1,861 positions worth $8.01B, up 6.6% from $7.51B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Janney Montgomery Scott deployed $334M of net new capital in Q2 2017, opening 128 new positions and adding to 1,041 existing holdings. Its largest new stake was Bright Horizons: 59,378 shares worth $4.58M.

By sector, the portfolio is most concentrated in Financials at 9% of assets, up from 8.7% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Vanguard Real Estate ETF, an estimated $7.64M trimmed.

  • Janney Montgomery Scott's largest Q2 2017 buy was Bright Horizons: 59,378 shares worth $4.58M.
  • Janney Montgomery Scott added most to iShares Core MSCI Emerging Markets ETF in Q2 2017, an estimated $17.6M increase.
  • Janney Montgomery Scott's biggest Q2 2017 reduction was Vanguard Real Estate ETF, cutting an estimated $7.64M.
  • Janney Montgomery Scott fully exited iShares Currency Hedged MSCI Japan ETF in Q2 2017, selling an estimated $6.47M.
  • Janney Montgomery Scott's ten largest holdings make up 13% of its $8.01B portfolio in Q2 2017.
  • Janney Montgomery Scott opened 128 new positions and closed 128 in Q2 2017.
  • Janney Montgomery Scott's portfolio value rose 6.6% quarter-over-quarter to $8.01B.

Based on Janney Montgomery Scott's 13F filing for Q2 2017, filed 27 Jul 2017.